DITABIS DIGITAL BIOMEDICAL IMAGING SYSTEMS AG

Their core work

DITABIS is a German SME specializing in digital biomedical imaging systems — hardware and software for capturing, processing, and analyzing biological images at microscopic and molecular scales. Within EU research consortia, they contribute imaging technology expertise to life science projects, particularly in advanced microscopy techniques such as light sheet microscopy, optical tweezers, and Raman spectroscopy. Their role is to provide the imaging tools and image processing capabilities that enable researchers to visualize biological processes in living organisms.

What they specialise in

How they've shifted over time

DITABIS entered H2020 with a focus on conventional optical microscopy and in vivo imaging — light sheet microscopy, optical tweezers, and high-throughput screening applied to developmental biology (cardiac and renal systems in zebrafish and mouse models). Their later projects signal a move toward spectroscopic imaging, with Raman spectroscopy appearing in the VISGEN project. This suggests a broadening from purely optical/fluorescence-based imaging toward molecular-level analytical imaging techniques.

DITABIS appears to be expanding from optical microscopy toward spectroscopic imaging methods like Raman, which could position them for label-free diagnostic and materials characterization applications.

How they like to work

DITABIS exclusively participates as a partner, never as coordinator — consistent with their role as a technology provider contributing specialized imaging capabilities to research-led consortia. Their 52 unique partners across 13 countries indicate they are well-networked and comfortable joining diverse, large consortia (typical of MSCA training networks). They function as an industry partner embedded in academic networks rather than a project driver.

With 52 consortium partners across 13 countries from just 4 projects, DITABIS has a broad European network built through MSCA training networks, which tend to have large, multi-institutional consortia. Their connections are predominantly in the academic life sciences and bioimaging communities.

What sets them apart

DITABIS occupies a niche as a private company building digital imaging systems specifically for biomedical research — bridging the gap between academic microscopy labs and commercial imaging solutions. Their consistent presence in MSCA training networks means they offer industry placements and real-world imaging expertise to early-stage researchers, making them a valuable partner for projects that need an industry host with genuine biomedical imaging capability. For consortium builders, they bring commercial-grade imaging technology and image analysis know-how without the overhead of a large corporation.

Highlights from their portfolio

• ImageInLife
  Largest funding (EUR 249,216) — a training network for multilevel bioimaging experts, reflecting DITABIS's core strength in imaging systems.
• 4DHeart
  Most keyword-rich project combining light sheet microscopy, optical tweezers, and high-throughput screening for 4D cardiac imaging — showcases their full technical range.
• VISGEN
  Smallest funding (EUR 4,500) but signals a strategic shift toward Raman spectroscopy and molecular visualization techniques.